Lauren Cornell




Lauren Cornell attended Texas A&M University under a Robert C. Byrd Scholarship, receiving her Bachelor of Science in Genetics in 2009. Following graduation, she joined a research team in the Zoology department at the University of Oxford until starting her Master’s degree in Biomedical Engineering through the joint program at the University of Texas Health Science Center at San Antonio (UTHSCSA) and the University of Texas at San Antonio (UTSA), graduating in 2012. After receiving her degree, she began a position at the United States Army Institute of Surgical Research (USAISR), Sensory Trauma Department, where she researches sensory therapeutics for wounded warriors.   

In 2015, while working at USAISR, she co-founded her company NovoThelium, which is focused on improving women’s health care, with a specific focus on improving nipple reconstruction post mastectomy. In 2016, she was accepted into the Translational Science Doctor of Philosophy program, a joint program with UT Austin, UTSA, and UTHSCSA, and further carried on her research in sensory trauma under the principles of translational science, while continuing to develop her startup. She graduated with her doctorate in 2019 with the honor of being chosen as the School of Biomedical Sciences Graduate Student Speaker. During her time as a student she was accepted into a Food and Drug Administration Fellowship, received a Military Health Young Investigator Award (Military Health System Research Symposium), and was selected for a scientific communication fellowship (Association for Research in Vision Ophthalmology) where she and had opportunity to lobby for scientific funding to Texas Representatives at the US Congress and Senate.

Her company, NovoThelium, has been awarded both nationally and internationally, has placed in ten business plan competitions, has been recognized by the Small Business Administration for “Women in Science Day”, and has been a platform company for discussion on medical advancements in women’s health.